chartexchange

Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND Acceptance

PR Newswire | Nov 19, 2026 2:06 AM EST

FDA clearance expands partnered molecular glue pipeline Achievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high unmet need HAMBURG, Germany, Nov. 19, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO)...

Read original article